Unravelling MyD88-dependent and independent mucosal immunity to Toxoplasma
揭示 MyD88 依赖性和独立的弓形虫粘膜免疫
基本信息
- 批准号:10735738
- 负责人:
- 金额:$ 42.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-18 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:AnimalsBiological Response ModifiersCell physiologyCellsCessation of lifeClassificationCytokine ReceptorsDiseaseEpithelial CellsEpitheliumEventFamilyGastrointestinal tract structureGenerationsHealthHealth HazardsHelminthsHost DefenseHost Defense MechanismHumanImmuneImmune responseImmune systemImmunityImmunocompromised HostImmunologic Deficiency SyndromesImmunologic MemoryInfectionInfection ControlInflammationInnate Immune ResponseInterferonsInterleukin-1Interleukin-12Intestinal MucosaIntestinesKnockout MiceLamina PropriaLeadLifeLymphoid CellMemoryMolecularMotionMouse StrainsMucosal Immune SystemMucosal ImmunityMucous MembraneMusNatural ImmunityOralOrganismOrganoidsOutcomeParasitesPathologyPathway interactionsPatternPhenotypePopulationProductionPublic HealthReceptor SignalingResearchResearch PersonnelResistanceResistance to infectionRoleRouteSeriesShapesSignal TransductionT memory cellT-LymphocyteToll-like receptor 11Toll-like receptorsToxoplasmaToxoplasma gondiiToxoplasmosisVaccinatedViralWorkadaptive immunitybiodefensecell typechronic infectioncongenital infectioncytokineeffector T cellemerging pathogenexperimental studygastrointestinal epitheliumgut microbiotahost microbiotahuman pathogenimprovedinsightintestinal epitheliumknockout animallong term memorymicrobialmicrobiotanovelopportunistic pathogenpathogenpathogenic microbeprofilinreceptorresistance mechanismresponsetool
项目摘要
Project Summary/Abstract
The long-term objective of this proposal is to understand inductive and effector mechanisms of host
defense in the intestinal mucosa. We use as a tool the intracellular protozoan Toxoplasma gondii, an orally
acquired opportunistic pathogen inducing strong protective Th1- and IFN--based immunity and that is a
significant health hazard in immunocompromised populations. Signaling through the adaptor molecule
MyD88 is necessary for optimal initiation of immunity and resistance to this pathogen. While IL-1 family
cytokine receptors use MyD88, the primary role of this signaling adaptor during T. gondii infection is
believed to be in Toll-like receptor (TLR) signaling. Nevertheless, the particular TLR involved (TLR11/12)
are not expressed in humans and indeed many other species, indicating presence of MyD88-independent
pathways of immune initiation. Such pathways are also present in mice, insofar as infection of MyD88
knockout animals triggers robust, albeit delayed, Th1 responses in the intestinal mucosa. Additionally,
MyD88 knockout mice can be vaccinated against lethal challenge with orally inoculated Toxoplasma. Open
questions remain regarding the role of MyD88 in specific cell types and in the context of the intestine how
the microbiota influences MyD88-dependent and MyD88-independent immunity during Toxoplasma
infection. The central hypothesis underpinning our research is that MyD88-dependent pathways and
MyD88-independent pathways work together to provide optimal immune initiation during infection. We will
address this hypothesis focusing on interactions between cells of the lamina propria, Toxoplasma and the
host microbiota. Using our hypothesis to guide us, we will pursue three specific aims. Aim 1: Determine
the role of intestinal epithelial cells in initiation of immunity and control of Toxoplasma. Using intestinal
organoids we will examine how epithelial cells respond to infection, and how this impacts responses in the
lamina propria compartment. The influence of epithelial MyD88 in immunity to T. gondii will be determined.
Aim 2: Identify how MyD88 impacts innate lymphoid cell (ILC) function during Toxoplasma infection. The
activity of ILC, with a focus on ILC1 and ILC3, will be examined using mouse strains deficient in ILC
populations and strains with deletion of MyD88 in ILC. Aim 3: Determine the influence of MyD88 expression
on generation of mucosal T cell effector and memory function. The requirement for MyD88 in lamina propria
T cells will be determined with regard to short term effector function and long-term memory function. The
importance of this research is that it will significantly extend and deepen our understanding of mechanisms
of resistance to Toxoplasma within the mucosal immune system, which is critical to understanding mucosal
host defense in humans. The ultimate impact of this research is that it can be expected to identify novel
parasite and host targets for promoting resistance and immunity during infection with Toxoplasma and other
microbial pathogens that threaten human health.
项目总结/摘要
本提案的长期目标是了解宿主的诱导和效应机制,
肠粘膜的防御。我们使用细胞内的弓形虫作为工具,
获得性机会致病菌诱导强保护性Th 1和IFN-γ免疫,
免疫功能低下人群中的重大健康危害。通过衔接分子的信号传导
MyD 88对于免疫和抵抗这种病原体的最佳起始是必需的。IL-1家族
细胞因子受体使用MyD 88,这是T.弓形虫感染是
Toll样受体(TLR)信号通路。然而,涉及的特定TLR(TLR 11/12)
在人类和许多其他物种中不表达,表明存在MyD 88非依赖性的
免疫启动的途径。这种途径也存在于小鼠中,只要感染MyD 88
敲除动物在肠粘膜中触发了强有力的,尽管是延迟的Th 1应答。此外,本发明还
MyD 88基因敲除小鼠可以接种疫苗以对抗口服接种的弓形虫的致死性攻击。开放
关于MyD 88在特定细胞类型中的作用以及在肠道中的作用,
弓形虫感染期间微生物群影响MyD 88依赖性和MyD 88非依赖性免疫
感染支撑我们研究的中心假设是MyD 88依赖性通路和
MyD 88独立途径共同作用,在感染期间提供最佳的免疫启动。我们将
解决这一假设的重点是细胞之间的相互作用,固有层,弓形虫和
宿主微生物群利用我们的假设来指导我们,我们将追求三个具体目标。目标1:确定
肠上皮细胞在启动免疫和控制弓形虫中的作用。使用肠
我们将研究上皮细胞如何对感染做出反应,以及这如何影响类器官中的反应。
固有层隔室。上皮细胞MyD 88对T.将确定是否感染弓形虫。
目的2:确定MyD 88在弓形虫感染期间如何影响先天淋巴细胞(ILC)功能。的
将使用ILC缺陷的小鼠品系检测ILC的活性,重点是ILC 1和ILC 3
ILC中MyD 88缺失的群体和菌株。目的3:确定MyD 88表达的影响
对黏膜T细胞效应子的产生和记忆功能的影响。固有层对MyD 88的需求
将关于短期效应功能和长期记忆功能来确定T细胞。的
这项研究的重要性在于,它将大大扩展和加深我们对机制的理解
在粘膜免疫系统中对弓形虫的抗性,这对于理解粘膜免疫系统至关重要。
人体的宿主防御这项研究的最终影响是,它可以预期确定新的
在弓形虫和其他寄生虫感染期间促进抵抗力和免疫力的寄生虫和宿主靶标
微生物病原体威胁人类健康。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Induction of IL-12p40 and type 1 immunity by Toxoplasma gondii in the absence of the TLR-MyD88 signaling cascade.
- DOI:10.1371/journal.ppat.1009970
- 发表时间:2021-10
- 期刊:
- 影响因子:6.7
- 作者:Snyder LM;Doherty CM;Mercer HL;Denkers EY
- 通讯作者:Denkers EY
From Initiators to Effectors: Roadmap Through the Intestine During Encounter of Toxoplasma gondii With the Mucosal Immune System.
- DOI:10.3389/fcimb.2020.614701
- 发表时间:2020
- 期刊:
- 影响因子:5.7
- 作者:Snyder LM;Denkers EY
- 通讯作者:Denkers EY
Impact of MyD88, Microbiota, and Location on Type 1 and Type 3 Innate Lymphoid Cells during Toxoplasma gondii Infection.
弓形虫感染期间 MyD88、微生物群和位置对 1 型和 3 型先天淋巴细胞的影响。
- DOI:10.4049/immunohorizons.2200070
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Snyder,LindsayM;Belmares-Ortega,Jessica;Doherty,ClaireM;Denkers,EricY
- 通讯作者:Denkers,EricY
Transcriptomics analysis of Toxoplasma gondii-infected mouse macrophages reveals coding and noncoding signatures in the presence and absence of MyD88.
- DOI:10.1186/s12864-021-07437-0
- 发表时间:2021-02-23
- 期刊:
- 影响因子:4.4
- 作者:Menard KL;Bu L;Denkers EY
- 通讯作者:Denkers EY
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIC Y DENKERS其他文献
ERIC Y DENKERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIC Y DENKERS', 18)}}的其他基金
New insights into early T cell protection during acute toxoplasmosis
急性弓形虫病期间早期 T 细胞保护的新见解
- 批准号:
10633247 - 财政年份:2022
- 资助金额:
$ 42.31万 - 项目类别:
MyD88-independent resistance to Toxoplasma in the intestine
MyD88 独立的肠道内对弓形虫的抵抗力
- 批准号:
10393513 - 财政年份:2018
- 资助金额:
$ 42.31万 - 项目类别:
MyD88-independent resistance to Toxoplasma in the intestine
MyD88 独立的肠道内弓形虫抵抗力
- 批准号:
9915889 - 财政年份:2018
- 资助金额:
$ 42.31万 - 项目类别:
Basis of MyD88-independent Th1 immunity during Toxoplasma infection
弓形虫感染期间不依赖 MyD88 的 Th1 免疫的基础
- 批准号:
9110482 - 财政年份:2016
- 资助金额:
$ 42.31万 - 项目类别:
Basis of MyD88-independent Th1 immunity during Toxoplasma infection
弓形虫感染期间不依赖 MyD88 的 Th1 免疫的基础
- 批准号:
9267461 - 财政年份:2016
- 资助金额:
$ 42.31万 - 项目类别:
Role of DC Wnt/beta-catenin signaling in Toxoplasma infection
DC Wnt/β-连环蛋白信号在弓形虫感染中的作用
- 批准号:
8619823 - 财政年份:2013
- 资助金额:
$ 42.31万 - 项目类别:
Role of intraepithelial T cells in Toxoplasma gondii-induced inflammatory ileitis
上皮内 T 细胞在弓形虫诱发的炎症性回肠炎中的作用
- 批准号:
7870442 - 财政年份:2009
- 资助金额:
$ 42.31万 - 项目类别:
Role of intraepithelial T cells in Toxoplasma gondii-induced inflammatory ileitis
上皮内 T 细胞在弓形虫诱发的炎症性回肠炎中的作用
- 批准号:
7706691 - 财政年份:2009
- 资助金额:
$ 42.31万 - 项目类别:
Role of CCL2/MCP-1 in mucosal immunity to Toxoplasma
CCL2/MCP-1在弓形虫粘膜免疫中的作用
- 批准号:
7282869 - 财政年份:2007
- 资助金额:
$ 42.31万 - 项目类别:
Role of CCL2/MCP-1 in mucosal immunity to Toxoplasma
CCL2/MCP-1在弓形虫粘膜免疫中的作用
- 批准号:
7475257 - 财政年份:2007
- 资助金额:
$ 42.31万 - 项目类别:
相似海外基金
Development of biological response modifiers of neurotrophins and their receptors
神经营养素及其受体生物反应调节剂的开发
- 批准号:
171953 - 财政年份:2008
- 资助金额:
$ 42.31万 - 项目类别:
Operating Grants
Collection, Storage, Advertisements, & Distribut of Biological Response Modifiers
收藏、保管、广告、
- 批准号:
7789037 - 财政年份:2006
- 资助金额:
$ 42.31万 - 项目类别:
Collection, Storage, Advertisements, & Distribut of Biological Response Modifiers
收藏、保管、广告、
- 批准号:
8089733 - 财政年份:2006
- 资助金额:
$ 42.31万 - 项目类别:
Design and development of biological response modifiers
生物反应调节剂的设计和开发
- 批准号:
14103018 - 财政年份:2002
- 资助金额:
$ 42.31万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Enhancement of PDT Using Biological Response Modifiers
使用生物反应调节剂增强 PDT
- 批准号:
7624158 - 财政年份:2001
- 资助金额:
$ 42.31万 - 项目类别:
Enhancement of PDT Using Biological Response Modifiers
使用生物反应调节剂增强 PDT
- 批准号:
7867872 - 财政年份:2001
- 资助金额:
$ 42.31万 - 项目类别:
ENHANCEMENT OF PDT USING BIOLOGICAL RESPONSE MODIFIERS
使用生物反应调节剂增强 PDT
- 批准号:
6616667 - 财政年份:2001
- 资助金额:
$ 42.31万 - 项目类别:
Enhancement of PDT Using Biological Response Modifiers
使用生物反应调节剂增强 PDT
- 批准号:
7440233 - 财政年份:2001
- 资助金额:
$ 42.31万 - 项目类别:
ENHANCEMENT OF PDT USING BIOLOGICAL RESPONSE MODIFIERS
使用生物反应调节剂增强 PDT
- 批准号:
6758547 - 财政年份:2001
- 资助金额:
$ 42.31万 - 项目类别:
ENHANCEMENT OF PDT USING BIOLOGICAL RESPONSE MODIFIERS
使用生物反应调节剂增强 PDT
- 批准号:
6261215 - 财政年份:2001
- 资助金额:
$ 42.31万 - 项目类别:














{{item.name}}会员




